Cortical Contributions to Motor Sequence Learning

Sponsor
Emory University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04138953
Collaborator
(none)
60
2
3
41.9
30
0.7

Study Details

Study Description

Brief Summary

The long-term objective initiated with this study is to determine which brain areas functionally contribute to learning a motor skill. The primary hypothesis of this trial is that premotor cortex (PMC) is necessary to learn a new motor skill. Participants may undergo a MRI scan to acquire a structural image of their brain to target noninvasive stimulation, using transcranial magnetic stimulation (TMS) to one of two brain areas: PMC or primary motor cortex (M1). A third group of individuals will undergo a placebo stimulation protocol. For all three groups, stimulation will be used to create a transient 'virtual lesion' during motor skill training. Temporarily disrupting the normal activity of these brain regions during training will allow us to determine which regions are causally involved in learning a new motor skill. The primary outcome measure will be the change in skill after training in each group.

Condition or Disease Intervention/Treatment Phase
  • Device: Transcranial Magnetic Stimulation (TMS)
  • Other: Sham TMS
N/A

Detailed Description

Recent findings in humans suggest that motor sequences are represented in the premotor cortex once learned. Studies in animal models have also shown that the premotor cortical areas encode sequence-specific information. However, it is currently unknown if premotor cortical areas are involved in the acquisition or consolidation of sequences in humans. In this project, the investigators will evaluate the functional contributions of human premotor cortex to sequence learning. The primary overarching research objective is to determine the brain regions causally involved in motor skill acquisition and consolidation. The main hypothesis is that disrupting premotor cortex activity during motor sequence learning will reduce the acquisition and consolidation of the skill. Transcranial magnetic stimulation (TMS) will be used to temporarily disrupt activity of premotor cortex or primary motor cortex, and skill learning will be assessed in both groups. A sham stimulation group, where participants will feel the coil on their head and hear the click of the TMS pulses but not actually receive stimulation to the brain, will be used as a control. Participants will be randomly assigned to be in the premotor cortex, primary motor cortex, or sham stimulation group. Participants may be asked to undergo a Magnetic Resonance Imaging (MRI) scan at Wesley Woods prior to TMS testing, which will occur at the Emory Rehabilitation Hospital. The MRI scan would be used to help target TMS to the intended brain area. Participants will be recruited using flyers around the local community. Consent forms will be provided with ample time for the participant to read it over and ask any questions that may arise. Participants will be compensated for their time. The proposed work will be the first to evaluate the causal role of premotor cortex in motor sequence learning in humans. Findings from this project are expected to inform the design and application of therapeutic interventions that improve motor functioning and learning in clinical populations.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Characterizing Cortical Contributions to Motor Sequence Learning
Actual Study Start Date :
Dec 5, 2019
Anticipated Primary Completion Date :
Jun 1, 2023
Anticipated Study Completion Date :
Jun 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: TMS over premotor cortex

Noninvasive brain stimulation in the premotor cortex

Device: Transcranial Magnetic Stimulation (TMS)
Transcranial magnetic stimulation, also known as repetitive transcranial magnetic stimulation, is a noninvasive form of brain stimulation in which a changing magnetic field is used to cause electric current at a specific area of the brain through electromagnetic induction. It will be used to create a 'virtual lesion,' disrupting neural activity in a specific brain region to identify whether it is causally involved in a specific behavioral process.
Other Names:
  • TMS
  • Experimental: TMS over primary motor cortex

    Noninvasive brain stimulation in the motor cortex

    Device: Transcranial Magnetic Stimulation (TMS)
    Transcranial magnetic stimulation, also known as repetitive transcranial magnetic stimulation, is a noninvasive form of brain stimulation in which a changing magnetic field is used to cause electric current at a specific area of the brain through electromagnetic induction. It will be used to create a 'virtual lesion,' disrupting neural activity in a specific brain region to identify whether it is causally involved in a specific behavioral process.
    Other Names:
  • TMS
  • Sham Comparator: Sham TMS over premotor cortex

    Sham brain stimulation in the premotor cortex

    Other: Sham TMS
    Sham Transcranial Magnetic Stimulation (TMS) over premotor cortex

    Outcome Measures

    Primary Outcome Measures

    1. Change in skill after training [Day 1 Post-intervention]

      Degree of sequence learning after receiving one of three types of stimulation: premotor cortex stimulation, primary motor cortex stimulation, or sham stimulation. Sequence-specific motor learning will be indexed by the difference in response time for repeated sequence responses compared to random sequence responses.

    Secondary Outcome Measures

    1. Change in cortical excitability after sequence learning. [Day 1 post-intervention]

      Evaluate the effect of sequence learning on motor cortical excitability. Cortical excitability will be indexed by peak-to-peak amplitudes of transcranial magnetic stimulation (TMS)-evoked electromyographic responses in the hand contralateral to the motor cortex targeted by TMS quantified before and after training.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 85 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • No history of movement impairment or neurodegenerative disease

    • Right handedness

    • No contraindication to transcranial magnetic stimulation (TMS) or magnetic resonance imaging (MRI).

    Exclusion Criteria:
    • Participants that are outside the age range of 18-85

    • Have a history of head trauma or neurodegenerative disorder

    • Report contraindications to TMS.

    • Participants over age 65 will be asked to complete the Montreal Cognitive Assessment, and participants with a score of 25 or lower (out of the "normal" range) will be excluded.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Emory University Atlanta Georgia United States 30322
    2 Wesley Woods Atlanta Georgia United States 30329

    Sponsors and Collaborators

    • Emory University

    Investigators

    • Principal Investigator: Michael Borich, DPT, PhD, Emory University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Michael R Borich, Assitant professor, Emory University
    ClinicalTrials.gov Identifier:
    NCT04138953
    Other Study ID Numbers:
    • IRB00115009
    First Posted:
    Oct 25, 2019
    Last Update Posted:
    Apr 28, 2022
    Last Verified:
    Apr 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    Yes
    Product Manufactured in and Exported from the U.S.:
    No
    Keywords provided by Michael R Borich, Assitant professor, Emory University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 28, 2022